FDA Authorizes Pfizer-BioNTech Booster for Older, High-Risk Individuals

The Food and Drug Administration (FDA) on Thursday authorized a third dose of Pfizer-BioNTech’s COVID-19 vaccine for older adults and those at high risk of severe illness or exposure to the virus.